Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Downs currently holds 241.57 shares of CNS Pharmaceuticals, Inc. (CNSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Downs has been a net buyer of CNSP stock. They have purchased $378.8K and sold $0 worth of shares.
Christopher Downs's most recent insider trade was on Apr 8, 2024, when they sold 40,000 shares at $0.00 per share.
Christopher Downs serves as Executive at CNS Pharmaceuticals, Inc. (CNSP). They have executed 14 insider transactions totaling $378.8K over their tenure at the company.
Christopher Downs holds the position of Executive at CNS Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Christopher Downs has shown a buying trading pattern, with $378.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Christopher Downs was on Aug 24, 2020, when they purchased $289.7K worth of CNSP shares. This transaction involved 142,000 shares at $2.04 per share.
Christopher Downs currently owns 241.57 shares of CNS Pharmaceuticals, Inc. (CNSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Downs's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Downs has 14 Form 4 filings on record as an insider at CNS Pharmaceuticals, Inc..
Set alerts for Christopher Downs and 40,000+ other insiders.